US Patent Issued to Legend Biotech USA on Aug. 11 for "CD19 binding molecules and uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,759, issued on Aug. 11, was assigned to Legend Biotech USA Inc. (Somerset, N.J.).

"CD19 binding molecules and uses thereof" was invented by Xiaohu Fan (Edmonton, Canada), Zhe Zhou (Nanjing, China), Qiuchuan Zhuang (Nanjing, China), Xu Fang (Nanjing, China), Yue Han (Nanjing, China), Youguo Peng (Nanjing, China) and Manman Lu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides single domain antibodies that bind to CD19, and chimeric antigen receptors comprising same. Further provided are engineered immune effector cells (such as T cells) comprising the chimeric antigen receptors. Pharmaceutical compositions,...